HEADER BLOOD CLOTTING 29-FEB-00 1EJ5 TITLE SOLUTION STRUCTURE OF THE AUTOINHIBITED CONFORMATION OF WASP COMPND MOL_ID: 1; COMPND 2 MOLECULE: WISKOTT-ALDRICH SYNDROME PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: WASP; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS ALPHA HELIX, BETA-HAIRPIN TURN, BLOOD CLOTTING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.S.KIM,L.T.KAKALIS,N.ABDUL-MANAN,G.A.LIU,M.K.ROSEN REVDAT 4 16-FEB-22 1EJ5 1 REMARK REVDAT 3 24-FEB-09 1EJ5 1 VERSN REVDAT 2 10-MAY-00 1EJ5 1 AUTHOR JRNL ATOM REVDAT 1 05-APR-00 1EJ5 0 JRNL AUTH A.S.KIM,L.T.KAKALIS,N.ABDUL-MANAN,G.A.LIU,M.K.ROSEN JRNL TITL AUTOINHIBITION AND ACTIVATION MECHANISMS OF THE JRNL TITL 2 WISKOTT-ALDRICH SYNDROME PROTEIN. JRNL REF NATURE V. 404 151 2000 JRNL REFN ISSN 0028-0836 JRNL PMID 10724160 JRNL DOI 10.1038/35010088 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.3, XPLOR 3.851, ARIA 1 REMARK 3 AUTHORS : BRUNGER, NILGES (CNS), BRUNGER (XPLOR), NILGES REMARK 3 (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURES ARE BASED ON A TOTAL OF 2713 RESTRAINTS, 2494 ARE REMARK 3 NOE-DERIVED REMARK 3 DISTANCE CONSTRAINTS, 182 DIHEDRAL ANGLE RESTRAINTS, 31 DISTANCE REMARK 3 RESTRAINTS REMARK 3 FROM HYDROGEN BONDS. REMARK 4 REMARK 4 1EJ5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1000010627. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298; 298; 298 REMARK 210 PH : 6.5; 6.5; 6.5; 6.5 REMARK 210 IONIC STRENGTH : 75MM; 75MM; 75MM; 75MM REMARK 210 PRESSURE : AMBIENT; AMBIENT; AMBIENT; REMARK 210 AMBIENT REMARK 210 SAMPLE CONTENTS : 1.6 MM PROTEIN U-15N; 25 MM REMARK 210 PHOSPHATE BUFFER PH 6.5, 50 MM REMARK 210 NACL, 1 MM EDTA, 2 MM DTT; 1.6 REMARK 210 MM PROTEIN U-15N,13C; 25 MM REMARK 210 PHOSPHATE BUFFER PH 6.5, 50 MM REMARK 210 NACL, 1 MM EDTA, 2 MM DTT; 1.6 REMARK 210 MM PROTEIN U-15N, 10% 13C; 25 MM REMARK 210 PHOSPHATE BUFFER PH 6.5, 50 MM REMARK 210 NACL, 1 MM EDTA, 2 MM DTT; 1.6 REMARK 210 MM PROTEIN U-15N,13C; 25 MM REMARK 210 PHOSPHATE BUFFER PH 6.5, 50 MM REMARK 210 NACL, 1 MM EDTA, 2 MM DTT REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; 4D_13C- REMARK 210 SEPARATED_NOESY; 4D_13C/15N- REMARK 210 SEPARATED_NOESY; HNHA; HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 1.7, NMRVIEW 2.1.2, VNMR REMARK 210 6.1B REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 14 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING STANDARD 3D AND 4D REMARK 210 HETERONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE ARG A 32 O SER A 77 1.55 REMARK 500 H PHE A 17 O LEU A 40 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 75 -36.72 179.23 REMARK 500 1 SER A 78 -40.31 168.88 REMARK 500 1 SER A 93 -41.01 82.10 REMARK 500 1 ARG A 94 20.69 -151.33 REMARK 500 1 HIS A 97 72.00 -67.72 REMARK 500 1 ASP A 104 104.96 -168.03 REMARK 500 2 SER A 99 95.32 -170.03 REMARK 500 2 ASP A 100 -177.24 62.87 REMARK 500 2 GLU A 101 -43.37 -144.41 REMARK 500 2 ASP A 104 95.17 40.44 REMARK 500 2 GLN A 105 108.41 -46.66 REMARK 500 3 SER A 72 176.67 51.80 REMARK 500 3 SER A 77 162.93 -49.08 REMARK 500 3 SER A 78 -57.32 77.85 REMARK 500 3 HIS A 97 66.81 -67.04 REMARK 500 3 SER A 99 -82.85 61.03 REMARK 500 4 SER A 7 176.53 59.88 REMARK 500 4 ASP A 18 52.81 -117.74 REMARK 500 4 SER A 77 95.88 -68.72 REMARK 500 4 SER A 78 -41.80 166.97 REMARK 500 4 SER A 99 123.12 60.58 REMARK 500 4 ASP A 100 98.18 59.72 REMARK 500 4 ASP A 104 95.81 42.13 REMARK 500 5 HIS A 5 71.84 -115.41 REMARK 500 5 HIS A 8 -53.36 79.21 REMARK 500 5 VAL A 9 -63.47 70.23 REMARK 500 5 SER A 72 125.81 64.09 REMARK 500 5 SER A 78 -44.38 175.11 REMARK 500 5 ILE A 96 102.09 -59.65 REMARK 500 5 SER A 98 56.62 76.53 REMARK 500 5 SER A 99 -173.94 -67.74 REMARK 500 5 ASP A 104 -164.71 40.86 REMARK 500 5 GLN A 105 114.71 69.47 REMARK 500 6 SER A 7 176.72 59.81 REMARK 500 6 HIS A 8 59.72 -166.80 REMARK 500 6 SER A 72 -83.22 59.88 REMARK 500 6 SER A 77 99.92 -68.70 REMARK 500 6 SER A 78 -48.25 179.35 REMARK 500 6 HIS A 97 92.62 -46.24 REMARK 500 6 GLU A 101 -36.41 178.86 REMARK 500 6 ASP A 104 38.26 39.76 REMARK 500 7 VAL A 9 -70.38 -163.87 REMARK 500 7 SER A 75 44.68 -109.03 REMARK 500 7 HIS A 97 88.47 -54.90 REMARK 500 7 SER A 99 74.33 -116.34 REMARK 500 7 ASP A 100 -46.09 -155.02 REMARK 500 7 GLN A 105 172.83 69.49 REMARK 500 8 SER A 7 -64.41 66.82 REMARK 500 8 HIS A 8 51.06 75.47 REMARK 500 8 ASP A 18 53.23 -118.20 REMARK 500 REMARK 500 THIS ENTRY HAS 122 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CEE RELATED DB: PDB REMARK 900 1CEE CONTAINS THE SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE REMARK 900 GTPASE BINDING DOMAIN OF WASP DBREF 1EJ5 A 1 69 UNP P42768 WASP_HUMAN 242 310 DBREF 1EJ5 A 76 107 UNP P42768 WASP_HUMAN 461 492 SEQADV 1EJ5 GLY A 70 UNP P42768 SEE REMARK 999 SEQADV 1EJ5 GLY A 71 UNP P42768 SEE REMARK 999 SEQADV 1EJ5 SER A 72 UNP P42768 SEE REMARK 999 SEQADV 1EJ5 GLY A 73 UNP P42768 SEE REMARK 999 SEQADV 1EJ5 GLY A 74 UNP P42768 SEE REMARK 999 SEQADV 1EJ5 SER A 75 UNP P42768 SEE REMARK 999 SEQRES 1 A 107 SER GLY PHE LYS HIS VAL SER HIS VAL GLY TRP ASP PRO SEQRES 2 A 107 GLN ASN GLY PHE ASP VAL ASN ASN LEU ASP PRO ASP LEU SEQRES 3 A 107 ARG SER LEU PHE SER ARG ALA GLY ILE SER GLU ALA GLN SEQRES 4 A 107 LEU THR ASP ALA GLU THR SER LYS LEU ILE TYR ASP PHE SEQRES 5 A 107 ILE GLU ASP GLN GLY GLY LEU GLU ALA VAL ARG GLN GLU SEQRES 6 A 107 MET ARG ARG GLN GLY GLY SER GLY GLY SER GLN SER SER SEQRES 7 A 107 GLU GLY LEU VAL GLY ALA LEU MET HIS VAL MET GLN LYS SEQRES 8 A 107 ARG SER ARG ALA ILE HIS SER SER ASP GLU GLY GLU ASP SEQRES 9 A 107 GLN ALA GLY HELIX 1 1 ASP A 23 ALA A 33 1 11 HELIX 2 2 SER A 36 THR A 41 1 6 HELIX 3 3 ASP A 42 GLN A 56 1 15 HELIX 4 4 GLY A 57 GLN A 69 1 13 HELIX 5 5 GLY A 80 MET A 89 1 10 HELIX 6 6 GLN A 90 SER A 93 5 4 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1